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An association between chronic marginal periodontitis and chronic obstructive pulmonary
disease (COPD) has been suggested. The aim of this study was to investigate whether
chronic marginal periodontitis is more prevalent in very severe COPD than in other very
severe respiratory diseases, and whether periodontitis in COPD is related to risk factors for
periodontitis that are often present in COPD subjects. Orthopantomograms were collected
from 130 patients with COPD and 50 patients with non-COPD evaluated for lung
transplantation. Chronic marginal periodontitis was defined as a general marginal bone
level X4mm. The prevalence of periodontitis was 44% in the COPD group vs. 7.3% in the
non-COPD group. All oral measurements differed significantly between the groups. The
difference in mean marginal bone level remained statistically significant when adjusting
for age, gender and pack years smoked. In logistic regression analysis mean marginal bone
level X4mm was identified as a factor significantly associated with severe COPD. This
study demonstrates that chronic marginal periodontitis is common in patients with severe
COPD. The high prevalence of periodontitis in COPD patients appears to be independent of
possible risk factors for periodontitis such as age, pack years smoked, body mass index, use
of corticosteroids and bone mineral density.
& 2008 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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o (I. Leuckfeld).Introduction
Chronic marginal periodontitis (periodontitis) is a destruc-
tive disease affecting the tooth-supporting tissues, including
the jawbone. Its course tends to be progressive, although
bursts can occur, and it is associated with imbalance
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COPD and periodontitis 489between the subgingival plaque, mainly consisting of Gram-
negative bacteria, and the host defense.1 Periodontitis is
highly prevalent, moderate-to-severe forms affecting
10–15% of the adult population.2,3 The prevalence increases
with age, and smoking and diabetes mellitus have been
identified as major risk factors for periodontitis.4 It is
increasingly recognized that periodontitis is associated with
a systemic inflammation,5,6 with a decrease in serum
C-reactive protein (CRP) levels after the treatment of
periodontitis.7
In recent years a possible association between periodontitis
and COPD has been proposed. A systematic review by
Azarpazhooh and Leake8 involving 728 papers discussing the
evidence for a possible etiological association between
respiratory disease and oral health identified four studies
concerning oral health indicators and COPD.9–12 Based on
those studies, Azarpazhooh and Leake8 concluded that there
is a poor evidence of weak association between COPD and oral
health. However, in two of the three reports addressing the
association between periodontal status and COPD the method
used for the measurement of periodontitis was clinical
examination.10,11 While clinical examination may give infor-
mation on the actual disease activity, periodontitis measured
from radiographs constitutes the consequences of past and
recent events of periodontal disease activity and may there-
fore be the best variable for studies of association.13,14 Also,
previous studies have used imprecise definitions of COPD when
reporting the association to periodontal status.10–12
Our aim was to investigate whether chronic marginal
periodontitis is more prevalent in subjects with very severe
COPD compared to patients with other very severe
respiratory diseases. To study the effect of periodontitis,
we wanted to use orthopantomograms of the jaws to
measure reduction in the marginal bone levels. Finally, we
wished to explore if chronic marginal periodontitis in very
severe COPD is related to known risk factors for period-
ontitis that are often present in COPD subjects.Materials and methods
A retrospective, cross-sectional study on a national sample
of all subjects (n ¼ 332) evaluated for lung transplantationFigure 1 Orthopantomogram with significant marginal bone loss i
cemento-enamel junction; MBL: marginal bone level; FUR: furcatioat the Rikshospitalet Medical Center in Oslo, Norway, from
1990 to 2005 was conducted. Of the 332 patients, 275 (83%)
had a dental journal, which included an orthopantomogram
(Figure 1).
All subjects were divided into two major groups, a COPD
group (n ¼ 161) and a non-COPD group (n ¼ 114). Since all
but two of the COPD subjects were former smokers, and
further statistical analysis necessitates adjustment for
smoking history, we excluded never-smokers from both
groups (n ¼ 61). Also, patients with alpha-1 antitrypsin
deficiency (n ¼ 29) were excluded from the COPD group
since they represent a separate entity of COPD. The non-
COPD group was represented by patients with idiopathic
pulmonary fibrosis (n ¼ 19), sarcoidosis (n ¼ 11), lymphan-
gioleiomyomatosis (n ¼ 5), primary pulmonary hypertension
(n ¼ 4), Eisenmenger syndrome (n ¼ 3) and miscellaneous
diseases (n ¼ 8).
Thus, 180 patients were included in the study, 130
patients in the COPD group and 50 patients in the non-COPD
group (Figure 2).
The study was approved by the local ethics committee.
Demographic variables were obtained from the patient
journals. If possible, smoking was defined in pack years,
otherwise as former smokers, since all patients had ceased
smoking before transplant evaluation. All subjects in the
COPD group were classified in the GOLD stage IV.15 At the
time of evaluation for transplantation circulating levels of
CRP and leukocytes, body mass index (BMI), bone mineral
density and information about use and dosage of systemic
corticosteroids, use of inhaled corticosteroids and other
immunosuppressive medication were recorded. Since high-
sensitivity CRP was not routinely taken, all CRP levels p5
were recorded as 5mg/L.Radiographic assessment
The orthopantomograms had been taken in a clinical setting
during the evaluation for the lung transplantation, and were
assessed retrospectively. Recordings from the blinded
orthopantomograms were conducted by two independent
examiners (IL, MVO-W) at two different time points. Oral
recordings included number of teeth, visible inter-radicularn a very severe COPD subject. ABC: alveolar bone crest; CEJ:
n (loss of interradicular bone).
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I. Leuckfeld et al.490radiolucency (furcation involvement) and marginal bone
level (Figure 1). The maximum number of teeth was 28 per
participant. Residual roots and third molars were excluded.
Furcation involvement on multirooted teeth was recorded as
present or not. The assessment of the marginal bone level
was performed with a millimeter-graded ruler (Somet,
Czech Republic) under  2 magnification using a magnifying
viewer16 and a light table with good illumination. The
marginal bone level distance was measured from the
cemento-enamel junction to the alveolar bone crest, at
the mesial and distal aspects of approximal tooth sites, and
was rounded off to the nearest 0.1mm. Each orthopanto-
mogram was divided in four quadrants. Marginal bone level
measurements were made if at least four measurements
could be performed in at least two quadrants. We then
calculated the mean marginal bone level per person.
Periodontitis was defined as a mean marginal bone level
X4mm, based on published data17 demonstrating that a
distance of X4mm constitutes a clearly pathological
condition.Table 1 Baseline characteristics in study participants.
Valid n Non-CO
Age (years) 180 47.07
Gender/female 180/101 21 (42
Pack years 136 13.77
Systemic steroids 180 29 (58
Dose (mg) 111 9.27
Inhaled steroids 180 12 (24
Immunosuppressives 180 4 (8.0
CRP (mg/L) 141 32.87
BMI (kg/m2) 167 22.77
Diabetes 180 0
L2–4 BMD (g/cm2) 69 1.074
Data are presented as mean7SD or n (%). COPD: chronic obstructive
prednisolone; immunosuppressives: other than steroids; CRP: C-reac
bone mineral density.
332 evaluated for lung transplantation
275 OPG present
114 non COPD 
-59 never smokers 
161 COPD
-2 never smokers
130 COPD 50 non COPD: 
19 IPF                11 sarcoidosis
5 LAM               4 PPH   
3 Eisenmenger   8 others 
55 non COPD 
-5 bronchiectasis 
159 COPD
-29 α1 ATD
Figure 2 Selection of study participants. OPG: orthopantomo-
gram; COPD: chronic obstructive pulmonary disease; a1-ATD:
alpha-1 antitrypsin deficiency; IPF: idiopathic pulmonary
fibrosis; LAM: lymphangioleiomyomatosis; PPH: primary pulmo-
nary hypertension.Statistical analyses
Descriptive statistics and statistical analyses were per-
formed with a computer package (SPSS PC+14.0, SPSS,
Inc., Chicago, IL, USA). The intraclass correlation coefficient
was used to calculate the intra- and inter-examiner
agreement of the distance measurements. Univariate
analysis of differences between the COPD- and the non-
COPD group was assessed by using independent samples
t-test for continuous variables; for category variables, the
Chi-square test or Fisher’s exact test was used. Linear
regression analysis was performed to calculate the influence
of selected variables on continuous oral measurements;
logistic regression analysis to calculate the influence of
selected variables on categorical oral measurements and to
determine the variables significantly associated with COPD.
Results were considered statistically significant if po0.05.
Results
Characteristics of former smokers in the non-COPD and COPD
group are summarized in Table 1. In 136/180 subjects, the
smoking history could be defined in pack years. The COPD
group was characterized by a higher number of pack years
(po0.001), a higher proportion of females (p ¼ 0.018), and
by being older than the non-COPD subjects (po0.001).
Radiographic examination
The mean marginal bone level could be calculated in 80/130
subjects with COPD and 41/50 subjects with non-COPD
according to the criteria for measurement (see Materials
and methods), with a maximum of 19 and a minimum of 4
(mean 8.473.3) measurements per person. Intraclass
correlation coefficient of the distance measurements was
0.98 and 0.96 for the intra- and inter-examiner correlation,
respectively.
The number of remaining teeth and the number of
edentulous subjects could be calculated in all the subjects.
Furcation involvement was possible to record in 85/130
COPD subjects and 43/50 non-COPD subjects.PD COPD p-Value
9.8 54.974.9 o0.001
.0) 80 (61.5) 0.018
11.9 26.9714.5 o0.001
.0) 82 (63.1) 0.53
5.0 6.771.8 0.011
.0) 103 (79.2) o0.001
) 0 0.005
43.7 11.7719.2 0.006
3.7 20.473.3 o0.001
3 (2.3) 0.56
70.199 0.89370.155 0.002
pulmonary disease; non-COPD: see Figure 1; systemic steroids:
tive protein; BMI: body mass index; L2–4 BMD: lumbal spine 2–4
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Table 3 Factors significantly associated with COPD in
former smokers evaluated for lung transplantation.
Variable Multivariate analysis
b p-Value OR (95% CI)
Age 0.166 0.004 1.2 (1.06–1.32)
Female 1.968 0.009 7.2 (1.64–31.30)
Pack years 0.099 0.008 1.1 (1.03–1.19)
mMBL X4mm 2.304 0.047 10.0 (1.03–97.47)
Logistic regression analysis with COPD (yes/no) as dependent
variable. mMBL: mean marginal bone level.
Table 2 Oral radiographic measurements in COPD and non-COPD former smokers.
Valid n Non-COPD COPD p-Value p-Value
mMBL (mm) 121 2.771.1 4.071.4 o0.001 0.045
mMBL X4mm 121 3 (7.3) 35 (43.8) o0.001 0.021
Furcation 128 1 (2.3) 14 (16.5) 0.019 NS
NRT 180 22.676.4 15.578.7 o0.001 NS
Edentulous 180 1 (2.0) 15 (11.5) 0.045 NS
Data are presented as mean7SD or n (%). mMBL: mean marginal bone level; furcation: furcation involvement; NRT: number of
remaining teeth; edentulous: toothless.
Adjusted for age, gender and pack years.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
m
M
B
L
 (
m
m
) all COPD
all non-COPD
COPDa
non-COPDa
102 95 80 41n=
Figure 3 Mean marginal bone level (mMBL) in COPD vs. non-COPD subjects; astudy participants (see Figure 2).
COPD and periodontitis 491All oral radiographic measurements differed significantly
between the two groups (Table 2). The difference in the mean
marginal bone level was 1.3mm (po0.001) (Figure 3) and the
periodontitis, defined as a reduced mean marginal bone level
X4mm, was present in 43.8% of the COPD subjects compared
to 7.3% of the non-COPD subjects (po0.001).
Regression analysis
In the linear regression analysis, with the mean marginal
bone level as a dependent variable, the difference between
the COPD and non-COPD group remained statistically
significant when adjusting for age, gender and pack years
smoked (po0.05) (Table 2).
In logistic regression analysis, with COPD (yes/no) as a
dependent variable, age (p ¼ 0.004), pack years (p ¼ 0.008),
female gender (p ¼ 0.009) and the mean marginal bone level
X4mm (p ¼ 0.047) were identified as factors significantly
associated with COPD (Table 3).
COPD subgroups
In the COPD group (n ¼ 80), 43.8% had periodontitis defined
as the mean marginal bone levelX4mm. The COPD subjectswith periodontitis (n ¼ 35) had more marginal bone loss
(mean marginal bone level 5.371.3 vs. 3.170.5mm,
po0.001), fewer teeth (17 vs. 22, po0.001) and more
frequent furcation involvement (21% vs. 5%, po0.05) than
the COPD subjects without periodontitis (n ¼ 45). However,
no significant differences in other characteristics such as
age, gender, pack years, BMI, bone mineral density or use of
steroids were found (Table 4).
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Table 4 Characteristics in COPD subgroups.
Valid n mMBL o4mm (n ¼ 45) mMBL X4mm (n ¼ 35) p-Value
Age (years) 80 54.075.6 55.074.3 0.39
Pack years 64 24.4712.9 26.6715.3 0.54
Gender/female 80 25 (55.6) 24 (68.6) 0.24
BMI (kg/m2) 75 20.773.7 20.573.3 0.80
Systemic steroids 80 27 (60.0) 24 (68.6) 0.43
Prednisolone (mg) 51 6.071.4 6.671.8 0.23
Inhaled steroids 80 35 (77.8) 30 (85.7) 0.37
Immunosuppressives 80 0 (0) 0 (0)
CRP (mg/L) 62 11.5724.2 13.1719.6 0.78
Leukocytes ( 109/L) 58 7.872.7 8.473.0 0.45
L2–4 BMD (g/cm2) 38 0.90670.159 0.90870.140 0.96
Data are presented as n (%) or mean7SD. mMBL: mean marginal bone level; BMI: body mass index; immunosuppressives: other than
steroids; CRP: C-reactive protein; L2–4 BMD: lumbal spine 2–4 bone mineral density.
I. Leuckfeld et al.492Discussion
In the present study, as the major radiographic sign of
periodontitis, marginal bone loss was significantly associated
with a very severe COPD, as assessed by the regression
analysis of data obtained from marginal bone level
measurements. The prevalence of periodontitis in the COPD
group was six times higher than that of our control group of
subjects evaluated for the lung transplantation due to
reasons other than COPD, and over three times higher than
that reported in the random Scandinavian populations
(12–13%).3,18
Our finding indicates a much stronger association between
periodontitis and COPD than that previously reported.8–12,19
The reason for this is unclear. In contrast to the most
previous studies of periodontitis association with COPD,
using clinical parameters of periodontitis, the method used
in our study to define periodontitis was based on radio-
graphs. This would seem to be a more objective parameter
of periodontitis than the clinical parameters obtained
through probing of periodontal pockets, since studies of
radiographs allow assessment of cumulative effects on
alveolar bone loss as a result of periodontal disease.13,14
However, the method used in this study is unlikely to explain
the stronger association between periodontitis and COPD
that we found.
We suggest that the high prevalence of periodontitis in
the COPD subjects could be explained by the severity of the
disease in the cohort studied. In the COPD group, all
investigated subjects had severe symptoms and poor lung
function (GOLD stage IV).15 If periodontitis has a role in
COPD deterioration, this could explain the high prevalence
in subjects with the worst outcome of the disease.
Smoking is a major common risk factor for COPD and
periodontitis, and some characteristics of the COPD subjects
could pose a risk for developing periodontitis. The pre-
valence of both COPD and periodontitis rises with ageing.
Malnutrition is a well-known complication of advanced COPD
and is associated with increased risk of chronic infections,
and as such a possible risk factor for periodontitis. Low bone
mineral density is related to the severity of COPD20 and in
postmenopausal Caucasian women osteopenia has beensuggested as a risk factor for periodontitis.21 Also, chronic
use of corticosteroids may result in osteopenia and has been
reported to involve the mandibula.22,23 However, profound
periodontal bone loss did not seem to be a prominent side-
effect of long-term corticosteroid treatment.23
Since our COPD group consisted of 99% former smokers,
statistical analyses could only be performed in former
smokers of both groups to properly adjust for smoking
history. In the regression analysis, smoking history, defined
as pack years smoked, gender and age could not explain the
significant difference in periodontitis prevalence in the
COPD and the non-COPD subjects that was found.
We then investigated if the high prevalence of period-
ontitis in the COPD subjects could be explained by variables
possibly associated with a higher risk for periodontitis. We
found no significant difference regarding age, gender, use of
corticosteroids, smoking history (pack years), BMI or bone
mineral density when comparing the COPD subjects with
radiological defined periodontitis and subjects without
radiographic signs of periodontitis. However, the limitations
of these findings are the relatively small number of subjects
in the control group and in the COPD subgroup analysis, and
that we could not adjust for socio-economic factors due to
the lacking data, low socio-economic status being associated
with both COPD and periodontitis.
Only a minority of smokers develop clinically significant
COPD, and even fewer develop very severe COPD at an age
when transplantation is an option. The high prevalence of
periodontitis in severe COPD that we found in our study may
be the result of the selection of highly inflammatory
susceptible subjects, and thus the coexistence of both
diseases could be a result of a genetic inflammatory
susceptibility. There are several other potential explana-
tions for an association between periodontitis and COPD.
Periodontitis may be linked to COPD through microbial
species, either by supporting colonization of dental plaque
with pulmonary pathogens,24 or by periodontal pathogens
and their products promoting airway inflammation and
exacerbations. Brook et al.25 found elevated antibody levels
towards Fusobacterium nucleatum and Prevotella interme-
dia, two important periodontal pathogens, in the sputum of
patients with an acute exacerbation of chronic bronchitis.
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COPD and periodontitis 493In a previous longitudinal study, using radiographic
alveolar bone loss for characterizing periodontitis, 1118
healthy men were examined for periodontitis at baseline
and followed for the subsequent risk of developing COPD
over a 25-yr period.12 The alveolar bone loss at the baseline
was found to be an independent risk factor for COPD, and
those subjects in the worst population quintile of bone loss
were found to be at a significantly higher risk (OR: 1.8; 95%
CI: 1.3, 2.5), supporting a possible role of periodontitis in
COPD pathogenesis or progression.
Pavord et al.26 has suggested that the coexistence of
multiple inflammatory stimuli may explain some of the
varied clinical consequences of chronic airway inflamma-
tion. A large number of cytokines and other biologically
active molecules are released continuously from the
chronically inflamed periodontium and peripheral mono-
nuclear cells. These pro-inflammatory mediators from
periodontal lesions could serve as an additional inflamma-
tory stimulus in COPD and induce a more severe inflamma-
tory response, with the result of more rapid airway disease
deterioration.
Since this is a retrospective cross-sectional study, we
cannot draw any conclusion regarding a cause-and-effect
association. A weakness of this study is the relatively small
number of subjects, both in the control group and in the
COPD subgroup analysis. However, within the limitations of
the present study, we demonstrated a significant relation-
ship between chronic marginal periodontitis and severe
COPD that appears to be independent of the possible risk
factors for periodontitis. Further research is needed to
elucidate this relationship; to assess if subjects with
periodontitis are at greater risk of developing COPD and if
treatment or prevention of periodontitis has an impact on
disease progression in COPD.Conflict of interest statement
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